Facebook
Twitter
LinkedIn
Forward
Pain Management & Opioids: A Patient-Centered Approach (P03 Evaluation)
The CO*RE 2024-2025 features a newly revised curriculum developed by nationally known experts in pain management, addiction, and opioids with a patient-centered approach. Content thoughtfully balances the risks and benefits of opioid prescribing, provides the latest insights in this vital healthcare area including effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options, managing patients on opioid, analgesics, educating patients and caregivers, and addressing opioid use disorder.
Sponsored by The American Academy of Hospice and Palliative Medicine, this newly updated course is designed to meet the FDA’s Opioid Analgesic REMS.
The course curriculum is fully compliant with the FDA’s September 2018 FDA Blueprint for Opioid Analgesic REMS Education and the 2022 Centers for Disease Control and Prevention (CDC) Clinical Practice Guideline for Prescribing Opioids for Pain. This session also meets many states’ requirements for controlled substances CE.
This course meets The Drug Enforcement Agency (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) Medication Access and Training Expansion (MATE) Act.
The curriculum was developed by the Collaborative for REMS Education (CO*RE) http://core-rems.org and is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies (RPC).
Target Audience
Hospice Medical Directors
HPM Physicians
Nurses
Nurse Practitioners
Pharmacists
PAs
Learning Outcomes
- Recognize the origin(s) and types of pain as they relate to pain management and opioid use disorder (OUD).
- Fully assess persons experiencing pain, including risk for OUD.
- Develop safe and effective pain management plans using nonpharmacologic and pharmacologic (non-opioid or opioid) options.
- Partner with patients to reduce risks when taking opioid therapy.
Disclosures
AAHPM endorses the Accreditation Council for Continuing Medical Education (ACCME) Standards for disclosure and commercial support and endeavors to ensure balance, independence, objectivity, and scientific rigor for all accredited products or programs. All who are in a position to control or influence the content of an educational activity must disclose any relevant financial relationships with ineligible companies.*Disclosure documents were reviewed for potential conflicts of interest and, if identified, were resolved prior to confirmation of participation. Only those who had no conflict of interest or who agreed to an identified resolution process prior to their participation were involved in this activity.
All editors, faculty and staff have disclosed no relevant financial relationships.
*An ineligible company is defined as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients.
Faculty
Arianna Campbell, MPH PA
Joe Shega, MD
Staff
Leah Farfan, BA
Julie Tanner, BSN RN-BC CHPN
Theresa Nissen, BA
Laura Witt, MS-HSM
Julie Bruno, MSW LCSW
Continuing Medical Education (CME)
The American Academy of Hospice and Palliative Medicine (AAHPM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Academy of Hospice and Palliative Medicine (AAHPM) designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion includes attesting to meaningful activity participation and completion/submission of activity evaluation within the time frame designated.
Evaluation period closes March 31, 2025 at 11:59 PM CT for claiming CME credit.
Maintenance of Certification (MOC)
This pre-conference workshop does not offer MOC credit.
Available Credit
- 3.50 CME (physician only)
- 3.50 Participation